Advanced Filters
noise
Found 64,783 clinical trials
A Aleksandr Krutko, PhD, MD

Minimally Invasive Posterior Decompression of the Cervical Spine

Degenerative stenosis of the cervical spinal canal may be caused by the compression of the posterior part of the dural sac and spinal cord by the hypertrophied ligamentum flavum and facet joints, by the compression of the anterior part of the dural sac and spinal cord by the posterior longitudinal …

18 years of age All Phase N/A
C Chuang Peng, PhD

HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC

The treatment options for unresectable HCC have rapidly developed, and immunotherapy has shown significant survival benefits in hepatocellular carcinoma. The STRIDE regimen of Single Tremelimumab (high, priming 300-mg dose) Regular Interval Durvalumab (1500 mg every 4 weeks) improved OS vs sorafenib in pts with unresectable HCC. In Asian region, HAIC …

18 - 70 years of age All Phase 2
J Jennifer Erdrich, MD

A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients

The purpose of this study is to assess the feasibility of a prehab intervention among American Indian (AI) patients diagnosed with obesity-related cancer and measure inflammatory biomarkers to evaluate the preliminary impact of the trial intervention. The central hypothesis is that this community-informed prehab intervention will demonstrate feasibility, patient acceptability, …

18 - 80 years of age All Phase N/A
K Kaini Shen

Teclistamab in Previously Treated AL Amyloidosis

This is a phase II study in patients with previously treated immunoglobulin light-chain (AL) Amyloidosis to evaluate the efficacy and safety of teclistamab

18 years of age All Phase 2
D Dilek Küçük Alemdar

Perioperative Preparation Application Developed for Children and Parents

Approaches to increase the compliance of children and parents in daily surgical interventions in children are limited. The primary aim of this study is to evaluate the clinical usability of the Paediatric Perioperative Preparation Game Application-PeroPap, which will be developed to prepare children and parents for day surgery. The secondary …

7 - 10 years of age All Phase N/A
K Kangshun Zhu, Dr.

Y-90 SIRT for Unresectable HCC Larger Than 7cm

This is a phase II clinical study to evaluate the efficacy and safety of SIRT in patients with HCC greater than 7 cm. After enrollment, patients received yttrium-90 selective internal radiation therapy. The primary endpoint of the study is objective reponse rate (ORR) as assessed by mRECIST. Secondary endpoints were: …

18 - 75 years of age All Phase 2
S Sara Chaszeyka

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

The purpose of this clinical investigation is to evaluate the safety and efficacy of Amnion/Chorion/Amnion allograft , Amnion/Chorion allograft, and/or Amnion/Amnion allograft, plus Standard of Care (SOC) each versus SOC alone in the treatment of chronic non-healing diabetic foot ulcers (DFU) after 12 weeks of treatment.

18 years of age All Phase N/A
C Costina R Poetar, Ph.D

Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression

The goal of this clinical trial is to test the efficacy of a transdiagnostic Internet-delivered interventions for Romanian adolescents with anxiety and/ or depression. The main questions it aims to answer are: What is the clinical efficacy of the Internet-delivered intervention? How accurate is the prediction model in predicting who …

13 - 17 years of age All Phase N/A
L Linnea Drew

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

The goal of this clinical trial is to understand if a new drug called LNS8801 can safely treat patients with melanoma. The primary question to be answered is what is the average length of time during which melanoma does not grow or spread after starting treatment with LNS8801? Researchers will …

18 years of age All Phase 2/3
C Cristina CC Colombo, MD

Ketamine Augmentation of ECT in Treatment-Resistant Depression

This is a randomized, double-blind, placebo-controlled phase 3 clinical trial evaluating the additive effect of intravenous ketamine in combination with electroconvulsive therapy (ECT) in patients with treatment-resistant major depressive disorder (MDD). The study aims to determine whether ketamine enhances the antidepressant efficacy of ECT and reduces associated cognitive side effects. …

18 - 70 years of age All Phase 3

Simplify language using AI